Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

626 trials with published results (16%)

Research Maturity

3091 completed trials (80% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.3%

167 terminated out of 3860 trials

Success Rate

94.9%

+8.4% vs benchmark

Late-Stage Pipeline

20%

762 trials in Phase 3/4

Results Transparency

20%

626 of 3091 completed with results

Key Signals

626 with results95% success167 terminated

Data Visualizations

Phase Distribution

3,236Total
Not Applicable (965)
Early P 1 (9)
P 1 (860)
P 2 (640)
P 3 (445)
P 4 (317)

Trial Status

Completed3,091
Unknown268
Terminated167
Recruiting117
Withdrawn95
Active Not Recruiting70

Trial Success Rate

94.9%

Benchmark: 86.5%

Based on 3091 completed trials

Clinical Trials (3860)

Showing 20 of 20 trials
NCT04900974Phase 1CompletedPrimary

Single Dose Pharmacokinetics of Doravirine in HIV-infected Pregnant Women

NCT07187648Not ApplicableCompletedPrimary

Golden Rice Cookies With Piper Crocatum for Blood Glucose Control and Quality of Life in People Living With HIV With Hyperglycemia

NCT04915768Phase 1CompletedPrimary

Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants.

NCT06665646Phase 1RecruitingPrimary

Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

NCT06074354Not ApplicableRecruitingPrimary

Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness

NCT05938803Not ApplicableActive Not RecruitingPrimary

PASEO Intervention for Adolescents Transitioning to Adult HIV Care in Urban Peru

NCT05044962Not ApplicableRecruitingPrimary

Kuwa Free! - Live Free!

NCT05816083Not ApplicableRecruiting

Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People

NCT01164462Not ApplicableCompletedPrimary

Feasibility and Limitations of Offering Community Based Rapid HIV Testing to Men Who Have Sex With Men (MSM)

NCT07525076Not ApplicableNot Yet RecruitingPrimary

Implementation of an Opt-Out Testing and Rapid Diagnostic Strategy for Syphilis and HIV in Pregnant Patients Presenting to the Emergency Department

NCT03256422Phase 3CompletedPrimary

Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients

NCT07525544Phase 1Not Yet RecruitingPrimary

A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants

NCT05357144Not ApplicableCompletedPrimary

AmbassADDOrs for Health Study

NCT04648046Phase 1RecruitingPrimary

CAR-T Cells for HIV Infection

NCT06627764Not ApplicableRecruiting

SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families

NCT00490074Phase 1CompletedPrimary

Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers

NCT00113282Phase 2CompletedPrimary

Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)

NCT00115609Phase 3CompletedPrimary

Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)

NCT07516548Not Yet RecruitingPrimary

Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV

NCT00120367Phase 2Completed

Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)

Scroll to load more

Research Network

Activity Timeline